Organon & Co
NYSE : OGNFinancials
Income statement · full history
USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
| Reported line item | Jan 1, 2019 to Dec 31, 2019 | Jan 1, 2020 to Dec 31, 2020 | Jan 1, 2021 to Dec 31, 2021 | Jan 1, 2022 to Dec 31, 2022 | Jan 1, 2023 to Dec 31, 2023 | Jan 1, 2024 to Dec 31, 2024 | Jan 1, 2025 to Dec 31, 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 7,777 | 6,532 | 6,304 | 6,174 | 6,263 | 6,403 | 6,216 |
| Cost of sales | 2,274 | 2,119 | 2,382 | 2,294 | 2,515 | 2,688 | 2,903 |
| Gross profit | 3,880 | 3,748 | 3,715 | 3,313 | |||
| Selling, general and administrative | 1,443 | 1,356 | 1,668 | 1,704 | 1,893 | 1,760 | 1,721 |
| Research and development | 220 | 210 | 339R | 471 | 528 | 469 | 366 |
| Acquired in-process research and development and milestones | 0 | 104 | 107 | 8 | 81 | 6 | |
| Goodwill impairment | 0 | 0 | 301 | ||||
| Restructuring costs | 78 | 60 | 3 | 28 | 62 | 31 | 95 |
| Interest expense | 0 | 258 | 422 | 527 | 520 | 504 | |
| Exchange losses | 44 | 4 | 11 | 42 | 26 | 14 | |
| Other (income) expense, net | 66 | (9)R | 17R | 15 | 15 | 21 | (119) |
| Income before income taxes | 3,696 | 2,752 | 1,529 | 1,122 | 673 | 807 | 425 |
| Total, costs expenses and otherno longer reported | 4,081 | 3,780 | 4,775 | 5,052 | 5,590 | ||
| Income tax expense (benefit) | 390 | 496 | 178 | 205 | (350) | (57) | 238 |
| Net income | 3,218 | 2,160 | 1,351 | 917 | 1,023 | 864 | 187 |
| Net Income From Continuing Operationsno longer reported | 3,306 | 2,256 | 1,351 | 917 | 1,023 | ||
| Basic (in dollars per share) | 12.69 | 8.52 | 5.33 | 3.61 | 4.01 | 3.36 | 0.72 |
| Loss From Discontinued Operations - Net of Taxno longer reported | (88) | (96) | 0 | 0 | 0 | ||
| Continuing operations (in dollars per share)no longer reported | 13.04 | 8.90 | 5.33 | 3.61 | 4.01 | ||
| Diluted (in dollars per share) | 12.69 | 8.52 | 5.31 | 3.59 | 3.99 | 3.33 | 0.72 |
| Discontinued operations (in dollars per share)no longer reported | (0.35) | (0.38) | 0.00 | 0.00 | 0.00 | ||
| Continuing operations (in dollars per share)no longer reported | 13.04 | 8.90 | 5.31 | 3.59 | 3.99 | ||
| Basic (in shares) | 253.52 | 253.52 | 253.54 | 254.08 | 255.24 | 257.05 | 259.5 |
| Discontinued operations (in dollars per share)no longer reported | (0.35) | (0.38) | 0.00 | 0.00 | 0.00 | ||
| Diluted (in shares) | 253.52 | 253.52 | 254.19 | 255.17 | 256.27 | 259.15 | 260.76 |
History starts FY2019, the period ended Dec 31, 2019 — the earliest period our structured-data source covers, not the company’s first year.
25 reported lines · 7 periods · values taken from the latest filing that prints each period.
- R3 restated by the filer — hover for the figure as first reported.
- italic14 from an earlier filing than the rest of the column.
- no longer reported7 lines the filer stopped printing.
- — the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.
151 of 151 values link to the exact element in the filer’s own document.
Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.
Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.